What is VasoCARE?
VasoCARE specializes in the development and distribution of portable DVT prevention devices tailored for hospital environments. Their product portfolio, including the Legacy IPC, is engineered to mitigate DVT risks and enhance patient adherence, while also addressing conditions such as chronic edema and diabetic foot ulcers. The company's core objective is to empower healthcare providers with innovative solutions that not only improve patient outcomes for vascular issues but also contribute to cost reduction by minimizing DVT-related complications.
How much funding has VasoCARE raised?
VasoCARE has raised a total of $34K across 1 funding round:
Debt
$34K
Debt (2021): $34K with participation from PPP
What's next for VasoCARE?
With the recent influx of expansion capital, VasoCARE is poised for significant scaling of its operations and market reach. The strategic investment will likely fuel further research and development into advanced vascular care technologies, alongside efforts to broaden the adoption of its existing DVT prevention and treatment devices within healthcare systems. This funding round signals a strong market validation and provides VasoCARE with the resources to solidify its position as a key player in the medical device industry, focusing on improving patient care and operational efficiency for hospitals.
See full VasoCARE company page
